Cargando…
Cardiac LXRα protects against pathological cardiac hypertrophy and dysfunction by enhancing glucose uptake and utilization
Pathological cardiac hypertrophy is characterized by a shift in metabolic substrate utilization from fatty acids to glucose, but the molecular events underlying the metabolic remodeling remain poorly understood. Here, we investigated the role of liver X receptors (LXRs), which are key regulators of...
Autores principales: | Cannon, Megan V, Silljé, Herman HW, Sijbesma, Jürgen WA, Vreeswijk-Baudoin, Inge, Ciapaite, Jolita, van der Sluis, Bart, van Deursen, Jan, Silva, Gustavo JJ, de Windt, Leon J, Gustafsson, Jan-Åke, van der Harst, Pim, van Gilst, Wiek H, de Boer, Rudolf A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4568954/ https://www.ncbi.nlm.nih.gov/pubmed/26160456 http://dx.doi.org/10.15252/emmm.201404669 |
Ejemplares similares
-
LXRα improves myocardial glucose tolerance and reduces cardiac hypertrophy in a mouse model of obesity-induced type 2 diabetes
por: Cannon, Megan V., et al.
Publicado: (2015) -
Cardiac Function and Architecture Are Maintained in a Model of Cardiorestricted Overexpression of the Prorenin-Renin Receptor
por: Mahmud, Hasan, et al.
Publicado: (2014) -
Regulation of the (pro)renin–renin receptor in cardiac remodelling
por: Mahmud, Hasan, et al.
Publicado: (2012) -
Cardiac complications in patients hospitalised with COVID-19
por: Linschoten, Marijke, et al.
Publicado: (2020) -
Telomere biology in healthy aging and disease
por: Oeseburg, Hisko, et al.
Publicado: (2009)